封面
市场调查报告书
商品编码
1518496

药筒市场- 按组件(柱塞、小瓶[玻璃、塑胶]、密封件)、类型(双室、大容量)、容量、使用设备(笔式註射器、自动注射器、穿戴式註射器)、应用、最终用户- 全球2024 - 2032 年预测

Pharmaceutical Cartridges Market - By Component (Plungers, Vials [Glass, Plastic], Seals), Type (Dual Chamber, Large-volume), Capacity, Usage Device (Pen Injectors, Autoinjectors, Wearable Injectors), Application, End-user - Global Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于全球药品生产的成长以及对积极支持高效药物输送和包装解决方案的强烈需求,预计 2024 年至 2032 年药品药筒市场规模的复合年增长率将达到 7.3%。随着药品生产的不断扩大,药筒被用来确保准确的剂量和无菌包装。

工程师和製造商正在关注材料和设计的进步,以满足製药行业不断变化的需求。这种成长正在提高药物输送系统的可靠性和效率,从而改善全球医疗保健结果。例如,2022年5月,肖特宣布投资数百万欧元用于即用型药筒生产,标誌着医药药筒的新时代。此措施有助于增强製造能力并满足对先进药物输送解决方案不断增长的需求。

整个市场分为组件、类型、使用设备、容量、应用程式、最终用户和区域。

就组件而言,密封件领域的药筒市场预计从2024 年到2032 年将录得显着的复合年增长率。性。製造商正在开发先进的密封技术以提高性能和可靠性。材料和设计方面不断涌现的创新也确保了与各种药物配方的兼容性,以维持药物在整个保质期内的功效和安全性。

从应用来看,由于对提供精确可靠的药物输送系统的强烈需求,心臟病学领域的药筒产业预计将在 2024 年至 2032 年期间成长。这些药筒增强了心臟病药物的管理,同时确保剂量一致并降低人为错误的风险。研究人员和医疗专业人员也在探索将这些墨盒整合到创新治疗方案中的新方法,以改善患者的治疗效果并简化心血管疾病的管理。

从区域来看,在病患安全和便利的推动下,亚太地区药用药筒市场规模预计将在 2024 年至 2032 年间呈现强劲成长,这将推动新兴市场的持续扩张。製造商正在开发可确保精确剂量和易于管理的药筒,以增强该地区的整体患者护理。随后,对改进的药筒设计和材料的需求不断增长,以支持更安全、更有效的治疗,同时透过用户友好的功能促进患者的依从性和舒适度,这将推动区域产品需求。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 对易于使用和方便的药品包装解决方案的需求不断增长
      • 药物传输和製造技术不断进步
      • 越来越关註生物製剂和个人化医疗的趋势
    • 产业陷阱与挑战
      • 製造复杂性
      • 严格的监管框架
  • 成长潜力分析
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按组成部分,2021 - 2032 年

  • 主要趋势
  • 柱塞
    • 氯化丁基橡胶
    • 溴化丁基橡胶
  • 小瓶
    • 玻璃
      • 类型1
      • 2型
      • 3型
    • 塑胶
      • 聚丙烯(PP)
      • 环烯烃共聚物(COC)
      • 环烯烃聚合物(COP)
      • 聚乙烯
      • 其他塑胶瓶
  • 密封件

第 6 章:市场估计与预测:按类型,2021 - 2032

  • 主要趋势
  • 双室墨盒
  • 大容量墨盒

第 7 章:市场估计与预测:按产能划分,2021 - 2032 年

  • 主要趋势
  • 0.5毫升
  • 1.8毫升
  • 2毫升至2.5毫升
  • 3毫升
  • 5毫升
  • 10毫升以上

第 8 章:市场估计与预测:按使用设备划分,2021 - 2032 年

  • 主要趋势
  • 笔式註射器
  • 自动注射器
  • 穿戴式註射器
  • 其他使用设备

第 9 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 牙齿保健
  • 糖尿病护理
  • 神经病学
  • 心臟病学
  • 肿瘤学
  • 其他应用

第 10 章:市场估计与预测:按最终用户划分,2021 年 - 2032 年

  • 主要趋势
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 家庭护理设置
  • 其他最终用户

第 11 章:市场估计与预测:按地区,2021 - 2032

  • 主要动向:按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区

第 12 章:公司简介

  • AptarGroup, Inc.
  • Baxter International Inc.
  • Dätwyler Holding Inc.
  • Gerresheimer AG
  • Merck KGaA
  • Nipro Corporation
  • Schott Group
  • Shandong Medicinal Glass Co., Ltd.
  • Stevanato Group
  • Transcoject GmbH
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
简介目录
Product Code: 9223

Pharmaceutical Cartridges Market size is projected to record 7.3% CAGR from 2024 to 2032, due to the rise in pharmaceutical production worldwide along with the strong need for actively supporting efficient drug delivery and packaging solutions. With the expanding pharmaceutical production, cartridges are used for ensuring accurate dosing and sterile packaging.

Engineers and manufacturers are focusing on advancements in materials and designs to meet the evolving needs of the pharmaceutical industry. This growth is enhancing reliability and efficiency in drug delivery systems for improved healthcare outcomes globally. For instance, in May 2022, SCHOTT announced a double-digit million Euro investment in ready-to-use cartridge production for marking a new era in pharmaceutical cartridges. This initiative helped in enhancing manufacturing capabilities and meeting the growing demand for advanced drug delivery solutions.

The overall market is segregated into component, type, usage device, capacity, application, end-user, and region.

In terms of component, the pharmaceutical cartridges market from the seals segment is expected to record significant CAGR from 2024 to 2032. Seals for pharmaceutical cartridges are used for ensuring the integrity and sterility of medications by preventing contamination and leakage. Manufacturers are developing advanced sealing technologies to enhance performance and reliability. Rising innovations in materials and designs are also ensuring compatibility with various drug formulations for maintaining the efficacy and safety of medications throughout their shelf life.

By application, the pharmaceutical cartridges industry from the cardiology segment is projected to rise from 2024 to 2032 owing to the strong need for providing precise and reliable drug delivery systems. These cartridges are enhancing the administration of medications for heart conditions whilst ensuring consistent dosages and reducing the risk of human errors. Researchers and medical professionals are also exploring new ways to integrate these cartridges into innovative treatment protocols to improve patient outcomes and streamline the management of cardiovascular diseases.

Regionally, the Asia Pacific pharmaceutical cartridges market size is projected to exhibit robust growth between 2024 and 2032, fueled by increasing expansion into emerging markets, driven by patient safety and convenience. Manufacturers are developing cartridges that ensure precise dosing and easy administration for enhancing overall patient care in the region. Subsequently, the growing need for improved cartridge designs and materials for supporting safer, more effective treatments whilst facilitating patient compliance and comfort with user-friendly features will drive the regional product demand.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for easy-to-use and convenient pharmaceutical packaging solutions
      • 3.2.1.2 Growing advances in pharmaceutical drug delivery and manufacturing technology
      • 3.2.1.3 Increasing focus on biologics and the trend towards personalized medicine
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Manufacturing complexity
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Million)

  • 5.1 Key trends
  • 5.2 Plungers
    • 5.2.1 Chlorinated butyl rubber
    • 5.2.2 Bromobutyl rubber
  • 5.3 Vials
    • 5.3.1 Glass
      • 5.3.1.1 Type 1
      • 5.3.1.2 Type 2
      • 5.3.1.3 Type 3
    • 5.3.2 Plastic
      • 5.3.2.1 Polypropylene (PP)
      • 5.3.2.2 Cyclic olefin copolymer (COC)
      • 5.3.2.3 Cyclic olefin polymer (COP)
      • 5.3.2.4 Polyethylene
      • 5.3.2.5 Other plastic vials
  • 5.4 Seals

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Million)

  • 6.1 Key trends
  • 6.2 Dual chamber cartridges
  • 6.3 Large-volume cartridges

Chapter 7 Market Estimates and Forecast, By Capacity, 2021 - 2032 ($ Million)

  • 7.1 Key trends
  • 7.2 0.5 ml
  • 7.3 1.8 ml
  • 7.4 2ml to 2.5 ml
  • 7.5 3 ml
  • 7.6 5 ml
  • 7.7 More than 10 ml

Chapter 8 Market Estimates and Forecast, By Usage Device, 2021 - 2032 ($ Million)

  • 8.1 Key trends
  • 8.2 Pen injectors
  • 8.3 Autoinjectors
  • 8.4 Wearable injectors
  • 8.5 Other usage devices

Chapter 9 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Million)

  • 9.1 Key trends
  • 9.2 Dental care
  • 9.3 Diabetes care
  • 9.4 Neurology
  • 9.5 Cardiology
  • 9.6 Oncology
  • 9.7 Other applications

Chapter 10 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Million)

  • 10.1 Key trends
  • 10.2 Hospitals
  • 10.3 Specialty clinics
  • 10.4 Ambulatory surgical centers
  • 10.5 Homecare settings
  • 10.6 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 AptarGroup, Inc.
  • 12.2 Baxter International Inc.
  • 12.3 Dätwyler Holding Inc.
  • 12.4 Gerresheimer AG
  • 12.5 Merck KGaA
  • 12.6 Nipro Corporation
  • 12.7 Schott Group
  • 12.8 Shandong Medicinal Glass Co., Ltd.
  • 12.9 Stevanato Group
  • 12.10 Transcoject GmbH
  • 12.11 West Pharmaceutical Services, Inc.
  • 12.12 Ypsomed AG